SILVERARC CAPITAL MANAGEMENT, LLC
Position in SNDX — Syndax Pharmaceuticals Inc
CIK 1816307
BOSTON, MA
Position in SNDX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,546,565
+$5,779,829 QoQ
Shares Held
1,214,390
+36.6% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
2.95%
of 13F equity value
Holder Rank
#28
of 242 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SILVERARC CAPITAL MANAGEMENT, LLC holds $802,586,993 across 53 Biotechnology names. SNDX ranks #10 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
206,234 | $55,006,732 | |
| 2 | CELC |
Celcuity Inc.
|
500,996 | $52,414,201 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,280,707 | $49,563,360 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
1,301,979 | $47,912,827 | |
| 5 | IMNM |
Immunome Inc.
|
2,017,009 | $42,740,420 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
390,000 | $38,017,200 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
311,461 | $34,581,514 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
352,802 | $33,576,166 |
All Filings in SNDX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,546,565 | 1,214,390 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $20,766,736 | 888,987 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $13,507,307 | 642,899 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,134,147 | 463,708 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,773,757 | 402,964 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,083,816 | 1,309,224 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $16,265,888 | 1,230,400 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,290,860 | 378,746 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,596,100 | 370,000 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $290,400 | 20,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $418,600 | 20,000 | Shares | Sole | 2023-08-14 | |
| 2022-06-30 | $2,075,072 | 107,852 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $1,763,148 | 101,447 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,189,000 | 100,000 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $596,262 | 34,727 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $447,200 | 20,000 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $667,200 | 30,000 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||